The Oncology Institute Adds Healthcare Legal Veteran as CLO Amid Expansion
Event summary
- The Oncology Institute (NASDAQ: TOI) appointed Minh Merchant as Chief Legal Officer on April 6, 2026.
- Merchant brings over 20 years of healthcare legal experience, including roles at Midi Health, Kyverna Therapeutics, Aspira Women’s Health, and McKesson.
- She will oversee legal, regulatory, compliance, and privacy functions as TOI scales its national oncology platform.
- TOI operates over 100 clinics across five states, serving approximately 1.9 million patients.
The big picture
The appointment of Minh Merchant as CLO underscores The Oncology Institute’s focus on strengthening its legal and regulatory framework amid rapid expansion. As value-based oncology care gains traction, TOI’s ability to manage compliance and privacy functions will be critical to its long-term success. With over 100 clinics and a growing patient base, the company is positioning itself as a key player in the community oncology space.
What we're watching
- Regulatory Compliance
- How Merchant’s expertise will navigate TOI through evolving healthcare regulations and compliance challenges.
- Scaling Strategy
- Whether TOI can sustain its growth trajectory while maintaining operational compliance across expanding markets.
- Legal Framework
- The pace at which TOI integrates Merchant’s legal and regulatory insights into its national oncology platform.
Related topics